01. Doctor Overview

Doctor Overview

Dr. Clamon has various specialties, including lung cancers. He has been affiliated with the esophageal cancer, lung cancer, and head and neck cancer clinics at the Holden Comprehensive Cancer Center at the University of Iowa Hospitals and Clinics, the only NCI-designated comprehensive center in the state of Iowa. Much of Dr. Clamon’s expertise can be seen through his publications, many of which focus on lung cancers.

02. Fast Facts

Doctor Fast Facts

Main Specialty: Oncology

Other Interests & Specialties: Hematologic oncology, general oncology, esophageal cancer, lung cancer, and head and neck cancers.

Certifications, Awards & Accolades: American Board of Internal Medicine Certifications in Internal Medicine and Medical Oncology

Education & Experience:

03. Publications


High-dose paclitaxel plus G-CSF for malignant mesotheliomaAnnals of Oncology. May 1999;10(5):597–600. doi: 10.1023/A:1026438215309

Effects of intravenous hyperalimentation during treatment in patients with small-cell lung cancerJournal of Clinical Oncology. July 1985; 3(7): 949-957. doi: 10.1200/JCO.1985.3.7.949

Radiotherapy plus razoxane for advanced limited extent carcinoma of the lungCancer. June 1984;53(9):1852-6.

Effect of adjuvant central iv hyperalimentation on the survival and response to treatment of patients with small cell lung cancer: a randomized trialCancer Treatment Reports. February 1985;69(2):166-67.

Chemoprevention and screening for lung cancer: changing our focus to former smokersClinical Lung Cancer. January 2015;16(1):1-5. doi: 10.1016/j.cllc.2014.09.009

Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597Journal of Clinical Oncology. November 2013;31(33):4179-4187. doi: 10.1200/JCO.2013.49.2173

Relationship between HER-2 overexpression and brain metastasis in esophageal cancer patientsWorld Journal of Gastrointestinal Oncology. May 2012;4(5):103-108. doi: 10.4251/wjgo.v4.i5.103

Advances in the systemic treatment of leptomeningeal cancer. Clinical Advances in Hematology & Oncology. March 2012;10(3):166-170.

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancerJournal of Clinical Oncology. May 2010;28(13):2181-2190. doi: 10.1200/JCO.2009.26.2543